Prebiopsy MRI Oncologically Safe for Suspected Prostate Cancer
Men with negative mpMRI results avoiding biopsy did not have increased risk for clinically significant prostate cancer
Platinum Chemo Shortage Led to Reduced Use, No Change in Mortality
Modest absolute reduction in use observed, which increased during peak of shortage; no difference seen in mortality during shortage
Proposed FDA Rule Targets Asbestos in Talc Cosmetic Products
Age Impacts Surgical Outcomes for Breast Reconstruction
Significant association seen for older age with increased risk for developing mastectomy skin flap/nipple necrosis, infection, seroma
U.S. Health Care Spending Reached $4.9 Trillion in 2023
Health sector's share of the economy was similar in 2023 and 2022, but lower than in 2020 and 2021, during height of COVID-19
FDA Approves Ryoncil for Steroid-Refractory Acute Graft-Versus-Host After Allo-HSCT
Ryoncil is first FDA-approved mesenchymal stromal cell therapy for pediatric patients aged 2 months or older
2000 to 2024 Saw Rise in Physician Union Petitions
Most organizing efforts motivated by nonfinancial factors
Fish Oil Supplementation Cuts Measure of Prostate Cancer Progression
Findings seen among men enrolled in one year of active surveillance
Early-Onset CRC Incidence Rates Increased in 27 of 50 Countries, Territories
Greatest increases in early-onset colorectal cancer incidence rates seen in New Zealand, Chile, Puerto Rico, and England
Disparities Seen in Biennial Mammography Screening for Women in in Their 40s
Biennial screening rates lower among non-Hispanic women with other race, lesbian and bisexual women, rural residents
